David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Kornit Digital
KRNT
$727M
| $2.75M | ﹤0.01% |
115,686
+55,223
| +91% | +$1.17M |
|
1902
iShares Russell 2000 ETF
IWM
$81.6B
| $2.74M | ﹤0.01% |
17,919
| – | – |
|
1903
PUT
ScottsMiracle-Gro
SMG
$3.57B
| $2.74M | ﹤0.01% |
34,900
-14,500
| -29% | -$1.09M |
|
1904
Titan International
TWI
$455M
| $2.74M | ﹤0.01% |
459,029
+70,675
| +18% | +$398K |
|
1905
PUT
Ligand Pharmaceuticals
LGND
$5.74B
| $2.74M | ﹤0.01% |
34,945
+6,251
| +22% | +$474K |
|
1906
CBRE Group
CBRE
$43.5B
| $2.73M | ﹤0.01% |
55,156
-202,532
| -79% | -$9.51M |
|
1907
PUT
Ulta Beauty
ULTA
$23.4B
| $2.72M | ﹤0.01% |
7,800
-40,000
| -84% | -$12.1M |
|
|
TSE
1908
DELISTED
Trinseo
TSE
| $2.71M | ﹤0.01% |
59,914
+10,053
| +20% | +$487K |
|
|
NPKI
1909
NPK International
NPKI
$1.12B
| $2.71M | ﹤0.01% |
296,064
-13,510
| -4% | -$116K |
|
|
KEYW
1910
DELISTED
The KEYW Holding Corporation
KEYW
| $2.7M | ﹤0.01% |
313,236
+105,448
| +51% | +$767K |
|
|
LKFT
1911
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.91B
| $2.7M | ﹤0.01% |
22,899
+3,806
| +20% | +$384K |
|
1912
Koppers
KOP
$876M
| $2.69M | ﹤0.01% |
103,651
-53,341
| -34% | -$1.25M |
|
|
AVLR
1913
DELISTED
Avalara, Inc.
AVLR
| $2.69M | ﹤0.01% |
48,272
+41,658
| +630% | +$1.93M |
|
1914
Silgan Holdings
SLGN
$4.54B
| $2.69M | ﹤0.01% |
90,856
-124,813
| -58% | -$3.44M |
|
1915
CALL
Eaton
ETN
$163B
| $2.69M | ﹤0.01% |
+33,400
| New | +$2.55M |
|
|
ARGO
1916
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.69M | ﹤0.01% |
38,084
-32,549
| -46% | -$2.21M |
|
1917
PUT
lululemon athletica
LULU
$13.2B
| $2.69M | ﹤0.01% |
16,400
-80,700
| -83% | -$11.8M |
|
|
MTSC
1918
DELISTED
MTS Systems Corp
MTSC
| $2.69M | ﹤0.01% |
49,314
-11,465
| -19% | -$582K |
|
1919
PUT
State Street
STT
$53.2B
| $2.69M | ﹤0.01% |
40,800
-50,100
| -55% | -$3.47M |
|
|
XLNX
1920
CALL
DELISTED
Xilinx Inc
XLNX
| $2.67M | ﹤0.01% |
+21,100
| New | +$2.37M |
|
|
DHC
1921
Diversified Healthcare Trust
DHC
$1.95B
| $2.67M | ﹤0.01% |
226,982
-1,120,985
| -83% | -$14.4M |
|
1922
Carter's
CRI
$1.26B
| $2.67M | ﹤0.01% |
26,446
-22,378
| -46% | -$2M |
|
1923
ADT
ADT
$5.44B
| $2.66M | ﹤0.01% |
415,928
+261,911
| +170% | +$1.89M |
|
|
CSW
1924
CSW Industrials
CSW
$5.26B
| $2.65M | ﹤0.01% |
46,341
+6,012
| +15% | +$325K |
|
|
ACHN
1925
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.65M | ﹤0.01% |
896,796
+441,973
| +97% | +$1.09M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.